Medtronic launches full U.S. distribution of Neuroguard IEP carotid stent system

Medtronic (NYSE: MDT)+ today announced the full U.S. rollout of the Neuroguard IEP system, a carotid stent and embolic protection device.

The launch follows a limited market release and builds on Medtronic’s exclusive U.S. distribution agreement with the device’s developer Contego Medical.

Neuroguard IEP combines a nitinol stent, dilation balloon and integrated filter in a single device designed to reduce the risk of stroke during carotid artery stenting. The integrated 40-micron filter captures microembolic debris that can be released during balloon dilation, which is a key source of stroke risk in carotid procedures.

Sign up for Blog Updates